Stubbs Alderton & Markiles, LLP, Southern California’s leading business law firm, is pleased to announce that attorney Oral Caglar has joined the firm as Senior Counsel in its Intellectual Property & Technology Transactions practice.
Oral is a registered patent attorney and a Certified Information Privacy Professional (CIPP/US). Oral’s practice focuses on technology transactions, licensing, data rights, and patent issues. He has worked throughout his career to resolve legal challenges for innovators who create and use technology. Before coming to the firm, Oral worked in-house for Fortune 100 companies in technology and entertainment, as well as in private practice at an Am Law 100 firm. He has worked in research university and federal laboratory environments, and he has driven technology transfer and development activities from both the university and industry sides.
Oral has an extensive background in negotiating commercial contracts for the development and delivery of hardware, on-premises software, and software-as-a-service (SaaS). Additionally, he has negotiated terms in government contracts and subcontracts, including for data rights, confidentiality, and technology collaboration. He also has deep experience in and has trained contracting professionals in the areas of intellectual property protection, supplier liability, contractual indemnity, and privacy.
About the Intellectual Property & Technology Transactions Practice
The attorneys at Stubbs Alderton & Markiles, LLP combine extensive transactional experience, intellectual property expertise, keen business insight, and a deep understanding of technology across a range of industries, within the United States and abroad. The firm’s tech-savvy team enables clients to leverage their intellectual capital to realize business objectives and achieve successful outcomes. The firm understands current business models and industry best practices and anticipates developments in the law to adapt to new technologies. Whether the firm is negotiating IP-driven commercial transactions, creating online contracts, securing university licenses, implementing corporate innovation programs, and patent protection strategies or developing policies and procedures to comply with privacy and data security laws and regulations, the firm delivers creative and pragmatic solutions for maximizing the value of its clients’ technology and intellectual property assets. Full description>>>
For more information about the Intellectual Property & Technology Transactions practice, contact Kevin D. DeBré at .
Stubbs Alderton & Markiles' client Sofie Biosciences, Inc, a developer of molecular imaging diagnostics and technologies to empower widespread access to Positron Emission Tomography (PET), announced last week that it has entered into a definitive agreement under which it will purchase Zevacor Pharma (previously IBA Molecular North America) and its high performance manufacturing and distribution network of PET imaging diagnostics and radio-therapeutics.
To read the full press release click here.
About Sofie Biosciences
SOFIE is a molecular imaging company combining new PET imaging diagnostics with innovative imaging and synthesis systems to provide researchers and physicians with tools to better investigate the biology of disease. By empowering a wide array of people with valuable, translational imaging tools, SOFIE is making PET scans more accessible. www.sofiebio.com
To find out more about Stubbs Alderton & Markiles’ Intellectual Property & Technology Transactions practice contact Kevin DeBré at